Regulation & policy

Meridia withdrawal has raised issue issue of sibutramine contamination

Wall Street Journal raises subatramine contamination question

By Shane Starling

Following last Friday’s decision by Abbott Laboratories to pull its sibutramine-containing weight loss drug Meridia due to concerns about side effects, questions are being asked about dietary supplement contamination with the substance.

Selenium qualified cancer claims: FDA approved (with disclaimer)

Selenium qualified health claims are usable, says attorney

By Shane Starling

The legal counsel who represented Durk Pearson, Sandy Shaw and others in the recent case that forced the Food and Drug Administration (FDA) to alter three approved selenium health claims, says his clients and others will use the claims.

EVEn keel: The claim-making furore hasn't stopped POM launching a provocative campaign

FTC complaint may influence other POM Wonderful legal actions

By Shane Starling

Pomegranate leader POM Wonderful and Pepsi-owned Tropicana – locked in a legal battle over juice claims – have been asked to submit comments about the complaint lodged against POM by the Federal Trade Commission last month.

Bisphenol A on the brink?

Bisphenol A on the brink?

By Rory Harrington

To BPA or not to BPA? While the European Food Safety Authority (EFSA) backed the continued use of bisphenol A last week, the real question is whether the verdict was a full-blown reprieve for the controversial chemical or merely a stay of execution.

POM: The legal saga rolls on

FTC bombs POM (and researchers beware)

By Shane Starling

The Federal Trade Commission legal action alleging POM Wonderful made unsubstantiated claims for its pomegranate products, adds to a stream of claim actions the increasingly active agency has taken this year.

POM: Engaged in legal battles on many fronts

Class action lodged against POM Wonderful

By Shane Starling

A class action has been lodged in a Florida state court alleging POM Wonderful misled consumers with at least six different health claims, as the Californian pomegranate pioneer’s legal battles multiply.

Pom Wonderful sues FTC over new claims standards

Pom Wonderful sues FTC over new claims standards

By Shane Starling

Pom Wonderful is suing the Federal Trade Commission (FTC) over new marketing standards of proof the Californian pomegranate leader says are damaging its brand equity.

FDA warns against Viagra coffee

FDA warns against Viagra coffee

By Shane Starling

A coffee product claiming to assist erectile dysfunction has been deemed an unapproved drug by the Food and Drug Administration (FDA) due to the presence of hydroxythiohomosildenafil, an analogue of sildenafil, used in the sexual aid Viagra.

EFSA set to mass reject 100s of herbal health claims

EFSA set to mass reject 100s of herbal health claims

By Shane Starling

Hundreds of proposed botanical-health relationships ranging from antioxidant activity to skin health to immunity to gut health will almost certainly be rejected if the European Food Safety Authority (EFSA) holds to its current methodologies, according...

GRAS approvals highlight Section 912 “nightmare”

GRAS approvals highlight Section 912 “nightmare”

By Shane Starling

Industry continues to urge the Food and Drug Administration to close the Section 912 loophole in the Federal Food, Drug, and Cosmetic Act (FDCA) that could allow nutrients such as omega-3s, L-arginine and baobab to be reclassified as drugs.

Follow us

Products

View more

Webinars